Poster Presentations

I. September 27, 2007

P1	The Potential of Two Non-Vaginal Routes of Misoprostol Administration Following Mifepristone for Medical Abortion Up to 63 Days Gestation
P2	Ability of Endometrial Thickness Following Medical Abortion to Predict Subsequent Surgical Intervention
P3	Serum Levels of Doxycycline at the Time of Dilation and Evacuation With Two Dosing Regimens
P4	Accuracy of Abdominal Ultrasonography in Determining Gestational Age and Outcomes in Early Medical Abortion
P5	Medical Abortion Outcomes after a Second-Dose of Misoprostol: Is the Presence of Cardiac Motion on Follow-Up Ultrasonography Predictive of Failure?
P6	Outcome of Medical Abortion Through 63 Days in Women With Prior Cesarean Section
P7	Misoprostol for Treatment of Early Pregnancy Failure in Women with Prior Uterine Surgery
P8	Predictors of Pain and Bleeding in Medical Abortion
P9	Predictors of Dilation and Curettage After Medical Abortion Through 63 Days Gestation
P10	The Provision of Medical Abortifacients by Pharmacies in Morelos, Mexico
P11	Eliciting Women’s Preferences in Medical Abortion Treatment Using Willingness to Pay
P12	Misoprostol Inhibits Innate Immune Defenses Against Clostridium Sordellii In Vitro
P13	Decreased Waiting Periods in a Public Pregnancy Termination Clinic
P14	Overcoming Barriers to offering Abortion Care in Family Medicine
P15	Incarcerated Women and Abortion Provision: A Survey of Services in Correctional Health Facilities
P16	African American Girls Views and Attitudes towards Abortion
P17	Emotional Prophylaxis for Abortion Patients: A Pilot Study
P18	Sex Selective Abortions Leading to Skewed Child Sex Ratio in An Urban Locality of East Delhi
P19	Prevalence of Chlamydia and Gonorrhea in a Public Pregnancy Termination Clinic
P20	HIV Testing Pregnant Women in Washington State
P21	A Nurse Directed Intervention Focusing On The Prevention of Sexually Transmitted Infections in African-American Women
P22	Sex, that Act, Intercourse, Doing It: The Language of Sexual Health in E-Mails to the Emergency Contraception Website
P23	There’s Always Plan B: Adolescent Knowledge, Attitudes and Intention to Use Emergency Contraception
P24	Emergency Contraception: Barrier Or Bridge to Effective Contraception?
P25	Access to Emergency Contraception on U.S. College Campuses
P26	Statewide EC Availability in Nebraska
P27	Emergency Contraception in Palestine: Assessing Retail Pharmacists’ Awareness, Opinions and Perceptions of Need
P28	An Animal Model of Uterine Auto and Allo-Transplantation With a Successful Pregnancy
P29	Intimate Partner Violence in Postpartum Women
P30	The Prevalence of Domestic Violence in Women Who Volunteer for Gynecologic Research Studies

II. September 28, 2007

P31	Prevalence and Social Correlates of Domestic Violence During Pregnancy; Evidence From a Lower Income Country
P32	Reproductive Health Issues in Women with Cancer: A Case Series Study
P33	Computerized Counseling About Folate: A Randomized Trial
P34	Evaluation of Sudanese Womens’ Sexual Life After Childbirth
P35	Strategies in Addressing Hispanic Reproductive Health
P36	Chronic Endometritis in Depot Medroxy-progesterone Acetate Users: Is Chlamydia Trachomatis a Cause?
P37	Depo Medroxyprogesterone Acetate (Dmpa) Use in Obese and Morbidly Obese Women: Incidence of Ovulation
P38	Effectiveness and Safety of the New Contraceptive: One Rode Implant – Implanon
P39	Increasing Utilization and Patterns of Use of The Levonorgestrel Intrauterine System – Data From a Large U.S. Health Plan
P40	Bleeding Patterns in Users of a 91-DAY Extended Regimen Oral Contraceptive with Low Dose Estrogen in a Place of Placebo Compared to a Conventional 28-Day Regimen
P41	Evaluation of 91-Day Extended Regimen Oral Contraceptive Continuation
P42	Evaluation of The Long-Term Safety of a 91-Day Extended Regimen Oral Contraceptive With Low-Dose Estrogen in Place of Placebo.
P43	Vaginal Ring Versus Combined Oral Contraceptives for Contraception: A Systematic Review
P44	Contraceptive Discontinuation Due to Method Dissatisfaction in the United States
P45	Medical Student Misinformation and Bias Regarding Elective Pregnancy Termination
P46	Does Vasectomy Explain the Difference in Tubal Sterilization Rates Between Black and White Women?
P47	Race and Desire for Tubal Sterilization Reversal
P48	FHI’s Decision to Halt Development of Quinacrine: Why and How
P49	Development of a Contraceptive Survey to Be Used in a Computerized tool Providing Personalized Output
P50	Clustering of Adolescent Females Seeking Family Planning Services at an Urban Clinic: Differences in Pregnancy Outcomes After One Year
P51	Contraceptive Preferences of Adolescent Mothers
P52	Perceptions of Oral Contraception Safety and Interest in Over-The-Counter Access Among a Predominantly Latina Population in Texas
P53	Health System Reforms to Promote Intra Uterine Device as a Spacing Method in India
P54	Refugee Family Planning: User Profiles From Mtendeli Refugee Camp in Kibondo, Tanzania
P55	Regional Quality Indicators Project-Journey into Quality Assurance: Pilot Phase through First Year of Data Collection and Reporting 1999-2005
P56	Understanding Trends and Factors that Influence Use of Withdrawal Among Hispanic, White and African American Women and Adolescents
P57	Unintended Pregnancy Has Measurable Effects on Women's Quality of Life
P58	Public and Private Providers Provision of Services, Their Views On The Problems Patients Have Using Contraception and Steps Needed to Improve Use
P59	Designing a Culturally Appropriate Family Planning Program: The Somali Child Spacing Project
P60	Pills, Dmpa, Sterilization and The Sdm: What Simulated Clients Tell Us About Provider Competence and Bias
P61	The Association of Body Mass Index and Unintended Pregnancy in the US: Results From Cycle 6 of The National Survey of Family Growth
P62	Unmet Family Planning Need Among U.S. Men